Drugmakers kicked off 2019 with price increases in the United States on more than 250 prescription drugs, including the world's top-selling medicine, Humira, although the pace of price hikes was slower than last year.
A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration.
China's agriculture ministry said on Wednesday that slaughterhouses will need run African swine fever virus test for pig products before selling them to the market, in a move to control spread of the highly contagious disease.
(Reuters Health) - LGBT patients treated in the emergency room (ER) are more comfortable reporting their sexual orientation on a medical form rather than in a discussion with a health care provider, a new study shows.
(Reuters Health) - In public mass shootings in the U.S., victims shot with a handgun were more likely to die than in the events associated with a rifle, according to a new study in the Journal of the American College of Surgeons.
A U.S. healthcare worker who may have been exposed to the Ebola virus while treating patients in the Democratic Republic of Congo arrived in the United States on Saturday and was put in quarantine in Nebraska.
(Reuters Health) - People who live in neighborhoods with more green spaces may have less stress, healthier blood vessels and a lower risk of heart attacks and strokes than residents of communities without many outdoor recreation areas, a small study suggests.
(Reuters Health) - International migrants who relocate to high-income countries to work, study or join family members are less likely to die prematurely than people born in their new homelands, a research review suggests.
(Reuters Health) - Despite warnings that supplemental testosterone may raise the risk of stroke and heart attack, doctors continue to prescribe the hormone off-label to men with cardiovascular disease, a U.S. study finds.
Progress in fighting Democratic Republic of Congo's Ebola outbreak, the second worst ever, will be reversed if fighting continues around the disease hotspots of Beni and Butembo, the head of the World Health Organization (WHO) said on Friday.